Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations
- PMID: 10474683
- PMCID: PMC395675
- DOI: 10.1136/mp.52.2.64
Malignant fibrous histiocytomas and H-ras-1 oncogene point mutations
Abstract
Aims: To investigate the types and the frequencies of H-ras-1 gene mutations in malignant fibrous histiocytomas.
Methods: Thirty five samples of malignant fibrous histiocytoma tissue were searched for point mutations within "hot spot" codons 12 and 13 of the H-ras-1 oncogene by the specific "nested" polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP) and a direct cycle sequencing procedure.
Results: In contrast to previous reports, none of the tumours contained a point mutation or any other changes within or around the hot spot gene sequences.
Conclusions: These data indicate that H-ras-1 oncogenic activation is not required in the molecular pathway of malignant fibrous histiocytoma formation and cannot be used as a discriminating factor for diagnostic sarcoma typing.
Similar articles
-
Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.Am J Pathol. 1996 Mar;148(3):731-8. Am J Pathol. 1996. PMID: 8774129 Free PMC article.
-
H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.Am J Clin Pathol. 2001 Feb;115(2):235-42. doi: 10.1309/HEF7-54YQ-JUVE-2THH. Am J Clin Pathol. 2001. PMID: 11211612
-
H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma.Hum Pathol. 2001 Nov;32(11):1225-31. doi: 10.1053/hupa.2001.28953. Hum Pathol. 2001. PMID: 11727262
-
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol. 1993 Aug;143(2):545-54. Am J Pathol. 1993. PMID: 8342602 Free PMC article. Review.
-
Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.Cancer Res. 1994 Apr 1;54(7 Suppl):1934s-1938s. Cancer Res. 1994. PMID: 7907948 Review.
Cited by
-
Atypical molecular background of glioblastoma and meningioma developed in a patient with Li-Fraumeni syndrome.J Neurooncol. 2005 Jan;71(1):27-30. doi: 10.1007/s11060-004-9181-3. J Neurooncol. 2005. PMID: 15719270
-
Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.Am J Pathol. 2013 Jun;182(6):2015-27. doi: 10.1016/j.ajpath.2013.02.035. Am J Pathol. 2013. PMID: 23708211 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous